- Home
- Biological Therapy Industry
- Gentium Market and Forecasts, May 2012
Top countries
Publication dates
All regions
data types
Gentium Market and Forecasts, May 2012
company reports
Gentium S.p.A. - Investment Analysis, December 2011
- Company report
- December 2011
- 7 pages
- by Corporation
... Application ("nda") for defibrotide, and we are hopeful that we would be in a position to file a new nda as early as 2012." As previously announced, gentium will host a conference call today (march 27 2012 ...
- Industries: Biological Therapy
Biogen Idec - Annual Report 2011
- Company report
- July 2011
- 106 pages
... With gentium to serve as their partner for distribution of defibrotide, a potentially life-saving therapy for bone marrow transplant patients; as well as a collaboration agreement with only for children ...
- Industries: Biopharmaceutical
- Countries: Sweden
Investor presentation: General Medicine and Specialty Medicine for Year 2011
- Company report
- March 2011
- 31 pages
... Agreement signed gentium / defibrotide -4% cer +11% cer discontinued products current portfolio, including co-promotion revenues note: partner products includes refacto co-promotion, kepivance ...
- Industries: General Medicine and Specialty Medicine
Reportlinker.com © Copyright 2012. All rights reserved
